Last reviewed · How we verify

NCT05255952: EpiCANS

Epicardial Stimulation of the Cardiac Autonomic Nervous System

Completed NA Last updated 27 September 2024
What this trial tests

NA trial testing Electrical stimulation in Cardiac Insufficiency in 4 participants. Completed in 13 November 2023.

Timeline
16 August 2022
Primary endpoint
13 October 2023
13 November 2023

Quick facts

Lead sponsorRennes University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment4
Start date16 August 2022
Primary completion13 October 2023
Estimated completion13 November 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Cardiac Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the EpiCANS study is to evaluate the technique of stimulation of the cardiac autonomic nervous system (SNAC) directly at the epicardial level in humans during heart surgery. Proof of concept study

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Electrical stimulation

Trials testing the same drug.

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05255952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing